Clinical outcomes of baloxavir versus oseltamivir in immunocompromised patients.

Matthew Ringer Maricar F MalinisDayna McManusMatthew DavisSunish ShahPaul TrubinJeffrey E TopalMarwan Mikheal Azar

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2024)

Baloxavir was not associated with longer time to resolution of hypoxia or fever in comparison to oseltamivir. Results must be taken in context of variations in seasonal influenza subtype and resistance rates.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
endothelial cells
patient reported outcomes
respiratory failure